Mer­ri­mack to dis­solve af­ter record­ing $225M mile­stone; Co­gen­t's $225M place­ment

Plus, news about Lari­mar Ther­a­peu­tics, Metageno­mi, Next­Point Ther­a­peu­tics, MeiraGTx, Codex­is, In­vi­tae, Im­munome and BioX­cel Ther­a­peu­tics:

Ipsen to pay $225M to Mer­ri­mack Phar­ma­ceu­ti­cals: The mile­stone pay­out …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER